GLP-1 RAs are more than weight-loss medications
The FDA-approved dosing schedule includes gradual titration specifically to improve gastrointestinal tolerability
Liposomal glutathione supplements are becoming increasingly popular for their superior absorption and effectiveness
Healthcare providers should evaluate and manage factors that may impede progress, including: Medications that promote weight gain (certain antidepressants, antipsychotics, corticosteroids, insulin, beta-blockers) Undiagnosed or suboptimally treated hypothyroidism Sleep disorders, particularly obstructive sleep apnoea Psychological factors including depression, anxiety, and eating disorders Social and environmental barriers to lifestyle change Patients who have not achieved expected weight loss with single-agent therapy should undergo comprehensive reassessment before considering any treatment changes
These medications mimic the action of a hormone called glucagon-like peptide-1 (GLP-1), which is naturally released after eating to regulate blood sugar and control appetite
Rather than simply suppressing symptoms, we can now target the underlying inflammatory pathways while simultaneously promoting repair and regeneration